Project Details
Short title | Phase 11 Open Label Study of CT-2106 as a Single Agent in Patients with Advanced Metastatic Ovarian Cancer Who Have Failed One Prior Platinum and Taxane Based Regimen... |
---|---|
Status | Finished |
Effective start/end date | 1/09/04 → 31/08/06 |
Funding
- CELL THERAPUTIC INC